EUVIMEDEUVIMED entdecken
Crossref

Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 73-73

DOI: 10.1111/ajco.70288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort. Asia-Pacific Journal of Clinical Oncology, 22(S6), 73-73. https://doi.org/10.1111/ajco.70288

Vancouver

Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):73-73. doi:10.1111/ajco.70288

BibTeX
@article{euvimed2026,
  title = {Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {73--73},
  doi = {10.1111/ajco.70288}
}
Kostenlos starten →